Rx Industry In Full Compliance With ClinicalTrials.gov, PhRMA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
PhRMA member companies maintain they are in compliance with ClinicalTrials.gov reporting requirements. The association argues that data cited recently by Rep. Waxman do not reflect the current rate of compliance.
You may also be interested in...
ClinicalTrials.gov Noncompliance By Industry Remains An FDA Concern
Despite “concerted” communications efforts by FDA, only 47% of clinical trials sponsored by industry are listed on registry website. Oncology Division Director Pazdur tells a House hearing that industry reluctance confuses the agency, which acknowledges “limited” enforcement capabilities.
Another Chance For VALID? Negative Reaction To FDA’s LDT Proposal May Reopen Legislative Talks
All of the witnesses testifying to a House E&C Committee hearing said they preferred the flexibility and targeted enforcement of the VALID Act to FDA’s proposed rule. Will Congress finally be spurred to act?
US FDA Advisory Panels May Look Different Across Centers, Despite Efforts To Standardize Process
As FDA is readying to go back to in-person advisory committee meetings this fall, the centers have different ideas about how to use their expert panels.